Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Sodium sulfate, potassium sulfate, magnesium sulfate

Also listed by the FDA as: magnesium sulfate, unspecified form / potassium sulfate / sodium sulfate · magnesium sulfate / potassium sulfate / sodium sulfate · magnesium sulfate anhydrous / potassium sulfate / sodium sulfate · magnesium sulfate, unspecified form / potassium sulfate / sodium sulfate anhydrous

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Sodium sulfate, potassium sulfate, magnesium sulfate key facts

Used for
Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult Patient. … (source)
Prescription or over the counter
Prescription (Rx)
Generic available
Yes
Typical pharmacy cost
$0.0887 per mL (magnesium sulfate 1.6 g/177 mL · potassium sulfate 3.13 g/177 mL · sodium sulfate 17.5 g/177 mL; NADAC)
Latest FDA recall
None listed

Sources: FDA label (September 18, 2026); FDA NDC Directory (November 13, 2026); CMS NADAC (November 11, 2026); FDA enforcement reports (November 10, 2026). Not medical advice.

Quick answers

What is Sodium sulfate, potassium sulfate, magnesium sulfate used for?
The FDA-approved label (Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, September 18, 2026) says: “Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult Patient. "Pediatric use information is approved for Braintree Laboratories, Inc.’s SUPREPBOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
What are the side effects of Sodium sulfate, potassium sulfate, magnesium sulfate?
The “Adverse Reactions” section of the FDA label (Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, September 18, 2026) begins: “The following important adverse reactions for bowel preparations are described elsewhere in the labeling: • Serious Fluid and Serum Chemistry Abnormalities [see Warnings and Precautions (5.1)] • Cardiac Arrhythmias [see Warnings and Precautions (5.2)] • Seizures [see Warnings and Precautions (5.3)] • Use in Patients with Risk of Renal Injury [see Warnings and Precautions (5.4)] • Colonic Mucosal Ulceration and Ischemic Colitis [see Warnings and Precautions (5.5)] • Patients with Significant Gastrointestinal Disease [see Warnings and Precautions (5.6)] • Aspiration [see Warnings and Precautions (5.7)] • Hypersensitivity Reactions [see Warnings and Precautions (5.8)] Most common adverse reactions are: • Adults (>2%): overall discomfort, abdominal distention, abdominal pain, nausea, and vomiting.” … This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
What are the drug interactions of Sodium sulfate, potassium sulfate, magnesium sulfate?
The “Drug Interactions” section of the FDA label (Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, September 18, 2026) begins: “Drugs that increase risk of fluid and electrolyte imbalance.” … This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Sodium sulfate, potassium sulfate, magnesium sulfate have a boxed warning?
No. None of the 13 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Sodium sulfate, potassium sulfate, magnesium sulfate?
No current shortage is listed by the FDA for the products of this medicine (FDA data from November 13, 2026).
Has Sodium sulfate, potassium sulfate, magnesium sulfate been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Sodium sulfate, potassium sulfate, magnesium sulfate?
13 companies list prescription products of Sodium sulfate, potassium sulfate, magnesium sulfate in the FDA NDC Directory, including Azurity Pharmaceuticals, Inc., Wilshire Pharmaceuticals, Inc. and Affordable Pharmaceuticals, LLC.

What Sodium sulfate, potassium sulfate, magnesium sulfate is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult Patient. "Pediatric use information is approved for Braintree Laboratories, Inc.’s SUPREPBOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution. …

— FDA label: Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, effective September 18, 2026. Read the full label on DailyMed →

Label quoted: the one for the most common form (solution, oral), Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited; it covers 1 product in the FDA NDC Directory. The side effects, interactions, dosage and pregnancy quotes below come from this same label.

The FDA has 13 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 13 FDA labels for this medicine have a boxed warning.

Sodium sulfate, potassium sulfate, magnesium sulfate side effects

Quoted from the “Adverse Reactions” section of the FDA-approved label. Tell your doctor about any side effect that worries you.

The following important adverse reactions for bowel preparations are described elsewhere in the labeling:

  • Serious Fluid and Serum Chemistry Abnormalities [see Warnings and Precautions (5.1)]
  • Cardiac Arrhythmias [see Warnings and Precautions (5.2)]
  • Seizures [see Warnings and Precautions (5.3)]
  • Use in Patients with Risk of Renal Injury [see Warnings and Precautions (5.4)]
  • Colonic Mucosal Ulceration and Ischemic Colitis [see Warnings and Precautions (5.5)]
  • Patients with Significant Gastrointestinal Disease [see Warnings and Precautions (5.6)]
  • Aspiration [see Warnings and Precautions (5.7)]
  • Hypersensitivity Reactions [see Warnings and Precautions (5.8)] Most common adverse reactions are:
  • Adults (>2%): overall discomfort, abdominal distention, abdominal pain, nausea, and vomiting.
Read more of this section

(6.1) To report SUSPECTED ADVERSE REACTIONS, contact Macleods Pharma USA, Inc. at 1-888-943-3210 or 1-855-926-3384 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical studies Experience Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in clinical studies of another drug and may not reflect the rates observed in practice. Adults The safety of Sodium sulfate, Potassium sulfate and Magnesium sulfate oral solution was evaluated in a multi-center, randomized, active controlled trial in 379 adult patients undergoing colonoscopy [see Clinical Studies (14)]. Most Common Adverse Reactions Table 1 shows the most common adverse reactions reported in at least 2% of patients receiving sodium sulfate, potassium sulfate and magnesium sulfate oral solution or the control (a bowel prep containing polyethylene glycol and electrolytes (PEG + E)) administered in split-dose (2-day) regimens. Table 1: Common Adverse Reactions* in Adult Patients Undergoing Colonoscopy in a Randomized, Active Controlled Trial Symptom Split-Dose (2-Day) Regimen Sodium sulfate, potassium sulfate and magnesium sulfate oral solution % N=190 PEG + E product % N=189 Overall Discomfort 54 67 Abdominal Distension 40 52 Abdominal Pain 36 43 Nausea 36 33 Vomiting 8 4 * reported in at least 2% of patients Laboratory Abnormalities Table 2 shows the most common laboratory abnormalities (at least 10% in either treatment group and more than 2% difference between groups) for patients who developed new abnormalities of important electrolytes and uric acid after completing the bowel preparation with either Sodium sulfate, Potassium sulfate and Magnesium sulfate oral solution or PEG+E administered as a split-dose (2-day) regimen.

Table from the label
SymptomSplit-Dose (2-Day) Regimen
Sodium sulfate, potassium sulfate and magnesium sulfate oral solution % N=190PEG + E product % N=189
Overall Discomfort5467
Abdominal Distension4052
Abdominal Pain3643
Nausea3633
Vomiting84

— FDA label: Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, effective September 18, 2026. This is part of the section. Read the full label on DailyMed →

Sodium sulfate, potassium sulfate, magnesium sulfate drug interactions

Quoted from the “Drug Interactions” section of the FDA-approved label. Tell your pharmacist about every medicine, vitamin and herbal product you take.

Drugs that increase risk of fluid and electrolyte imbalance.

Read more of this section

(7.1) 7.1 Drugs That May Increase Risk of Fluid and Electrolyte Abnormalities Use caution when prescribing sodium sulfate, potassium sulfate and magnesium sulfate oral solution to patients taking medications that increase the risk of fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities [see Warnings and Precautions (5.1, 5.2, 5.3, 5.4)]. 7.2 Potential for Reduced Drug Absorption Sodium sulfate, potassium sulfate and magnesium sulfate oral solution can reduce the absorption of other co-administered drugs [see Dosage and Administration (2.1)].

  • Administer oral medications at least one hour before starting each dose of sodium sulfate, potassium sulfate and magnesium sulfate oral solution
  • Administer tetracycline and fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, and penicillamine at least 2 hours before and not less than 6 hours after administration of Sodium sulfate, Potassium sulfate and Magnesium sulfate oral solution to avoid chelation with magnesium. 7.3 Stimulant Laxatives Concurrent use of stimulant laxatives and sodium sulfate, potassium sulfate and magnesium sulfate oral solution may increase the risk of mucosal ulceration or ischemic colitis. Avoid use of stimulant laxatives (e.g., bisacodyl, sodium picosulfate) while taking sodium sulfate, potassium sulfate and magnesium sulfate oral solution [see Warnings and Precautions (5.5)].

— FDA label: Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, effective September 18, 2026. Read the full label on DailyMed →

Sodium sulfate, potassium sulfate, magnesium sulfate dosage

Quoted from the “Dosage and Administration” section of the FDA-approved label. Your own dose is the one your doctor prescribes: do not change it on your own.

Preparation and Administration (2.2)

  • Must dilute in water prior to ingestion.
  • Administration of two bottles of Sodium sulfate, Potassium sulfate and Magnesium sulfate oral solution is required for a complete preparation for colonoscopy. One bottle is equivalent to one dose.
  • Must consume additional water after each dose.
  • Stop consumption of all fluids at least 2 hours before the colonoscopy.
Read more of this section

Recommended Dosage and Administration

  • Split-Dose (two-day) regimen consists of two doses of Sodium sulfate, potassium sulfate and magnesium sulfate oral solution first dose during the evening prior to colonoscopy and second dose the next day, during the morning of colonoscopy. (2.1, 2.3)
  • Recommended Sodium sulfate, potassium sulfate and magnesium sulfate oral solution dosage is: o Adults: Two 6-ounce doses. (2.3)
  • For complete information on preparation before colonoscopy and administration of the dosage regimen, see full prescribing Information. (2.1, 2.2, 2.3) 2.1 Dosage and Administration Overview Administration of two bottles of sodium sulfate, potassium sulfate and magnesium sulfate oral solution and additional water is required for a complete preparation for colonoscopy. One bottle of Sodium sulfate, Potassium sulfate and Magnesium sulfate oral solution is equivalent to one dose. Sodium sulfate, Potassium sulfate and Magnesium sulfate oral solution is supplied in one dosage strength [see Dosage Forms and Strengths (3)]. The recommended dosage is:
  • Adults: Two 6-ounce doses [see Dosage and Administration (2.3)]. "Pediatric use information is approved for Braintree Laboratories, Inc.’s SUPREPBOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution. However, due to Braintree Laboratories, Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information." 2.2 Important Preparation and Administration Instructions
  • Correct fluid and electrolyte abnormalities before treatment with sodium sulfate, potassium sulfate and magnesium sulfate oral solution [see Warnings and Precautions (5.1)]
  • Must dilute sodium sulfate, potassium sulfate and magnesium sulfate oral solution in water before ingestion.
  • Must consume additional water after each dose of sodium sulfate, potassium sulfate and magnesium sulfate oral solution.
  • On the day before colonoscopy, consume only a light breakfast or clear liquids (e.g., water, strained fruit juice without pulp, lemonade, plain coffee or tea, chicken broth gelatin dessert without fruit). On the day of the colonoscopy only consume clear liquids up to two hours prior to colonoscopy.
  • Do not eat solid food or drink milk or eat or drink anything colored red or purple.
  • Do not drink alcohol.
  • Do not take other laxatives while taking sodium sulfate, potassium sulfate and magnesium sulfate oral solution.
  • Do not take oral medications within one hour of starting each dose of sodium sulfate, potassium sulfate and magnesium sulfate oral solution.

— FDA label: Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, effective September 18, 2026. This is part of the section. Read the full label on DailyMed →

Sodium sulfate, potassium sulfate, magnesium sulfate in pregnancy

Quoted from the pregnancy part of the FDA-approved label. Ask your doctor before you take any medicine while pregnant or planning a pregnancy.

Risk Summary There are no available data on sodium sulfate, potassium sulfate and magnesium sulfate oral solution use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Animal reproductive studies have not been conducted with sodium sulfate, potassium sulfate, and magnesium sulfate (sodium sulfate, potassium sulfate and magnesium sulfate oral solution).

Read more of this section

The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.

— FDA label: Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, effective September 18, 2026. Read the full label on DailyMed →

When Sodium sulfate, potassium sulfate, magnesium sulfate should not be used

Quoted from the “Contraindications” section of the FDA-approved label.

Sodium sulfate, Potassium sulfate and Magnesium sulfate oral solution is contraindicated in the following conditions:

  • Gastrointestinal obstruction or ileus [see Warnings and Precautions (5.6)]
  • Bowel perforation [see Warnings and Precaution (5.6)]
  • Toxic colitis or toxic megacolon
  • Gastric retention
  • Hypersensitivity to any of the ingredients in sodium sulfate, potassium sulfate and magnesium sulfate oral solution [see Warnings and Precautions (5.8) and Description (11)]
  • Gastrointestinal obstruction or ileus (4, 5.6)
  • Bowel perforation (4, 5.6)
  • Toxic colitis or toxic megacolon (4)
  • Gastric retention (4)
  • Hypersensitivity to any ingredient (4, 5.8)

— FDA label: Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, effective September 18, 2026. Read the full label on DailyMed →

Sodium sulfate, potassium sulfate, magnesium sulfate overdose

Quoted from the “Overdosage” section of the FDA-approved label. If someone may have taken too much, call Poison Help at 1-800-222-1222 (or 911 in an emergency).

Overdosage of more than the recommended dose of sodium sulfate, potassium sulfate and magnesium sulfate oral solution may lead to severe electrolyte disturbances, as well as dehydration and hypovolemia, with signs and symptoms of these disturbances. [see Warnings and Precautions (5.1, 5.2, 5.3)]. Monitor for fluid and electrolyte disturbances and treat symptomatically.

— FDA label: Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, effective September 18, 2026. Read the full label on DailyMed →

Forms and how it is given

Dosage formsSolution · Solution, concentrate
RouteOral
Prescription products17 in the FDA NDC Directory
Brand namesSuprep Bowel Prep, Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Bowel Prep Kit

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Sodium sulfate, potassium sulfate, magnesium sulfate, by strength and form
Strength and formGeneric or brandPharmacies pay
magnesium sulfate 1.6 g/177 mL · potassium sulfate 3.13 g/177 mL · sodium sulfate 17.5 g/177 mL
solution
Generic $0.0887 per mL
magnesium sulfate anhydrous 1.6 g/177 mL · potassium sulfate 3.13 g/177 mL · sodium sulfate 17.5 g/177 mL
solution
Generic $0.0887 per mL
magnesium sulfate, unspecified form 1.6 g/177 mL · potassium sulfate 3.13 g/177 mL · sodium sulfate 17.5 g/177 mL
solution
Generic $0.0887 per mL
magnesium sulfate, unspecified form 1.6 g/177 mL · potassium sulfate 3.13 g/177 mL · sodium sulfate anhydrous 17.5 g/177 mL
solution
Generic $0.0887 per mL
magnesium sulfate, unspecified form 1.6 g/mL · potassium sulfate 3.13 g/mL · sodium sulfate 17.5 g/mL
solution, concentrate
Generic $0.0887 per mL
magnesium sulfate, unspecified form 1.6 g/mL · potassium sulfate 3.13 g/mL · sodium sulfate 17.5 g/mL
solution, concentrate
Brand: SUPREP Bowel Prep $0.3246 per mL

NADAC list of November 11, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA022372
SUPREP BOWEL PREP KIT
AzurityAugust 5, 2010 5, latest November 18, 2025
2025: Labeling · 2020: Efficacy · 2012: Labeling

Generic approvals (7)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)1001689, 1001690, 1120068, 2390767, 2390768
SPL set ID of the quoted labele56e8f90-51f5-4f51-9b6b-a6f5a2e499cc
FDA labels (SPL)13
FDA applicationsNDA022372, 7 ANDA
Active ingredients (FDA)MAGNESIUM SULFATE / POTASSIUM SULFATE / SODIUM SULFATE

Next steps

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral, Macleods Pharmaceuticals Limited, effective September 18, 2026; via openFDA, FDA data exported November 13, 2026, retrieved November 14, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers